Viewing StudyNCT00305617



Ignite Creation Date: 2024-05-05 @ 4:44 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00305617
Status: COMPLETED
Last Update Posted: 2011-05-17
First Post: 2006-03-21

Brief Title: Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer
Sponsor: The Cleveland Clinic
Organization: The Cleveland Clinic

Organization Data

Organization: The Cleveland Clinic
Class: OTHER
Study ID: CASE-CCF-6503
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: The Cleveland Clinic
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH